Study on the Common Problems of and Countermeasures for the Supervision of Institutions for Drug Clinical Trial

Ding Zhenglei, Cong Luoluo, Wu Bin

Chinese Pharmaceutical Affairs ›› 2018, Vol. 32 ›› Issue (3) : 299-304.

Chinese Pharmaceutical Affairs ›› 2018, Vol. 32 ›› Issue (3) : 299-304. DOI: 10.16153/j.1002-7777.2018.03.001
Supervision Administration

Study on the Common Problems of and Countermeasures for the Supervision of Institutions for Drug Clinical Trial

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2018, 32(3): 299-304 https://doi.org/10.16153/j.1002-7777.2018.03.001

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉